valsartan has been researched along with Focal Segmental Glomerulosclerosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asada, N; Awazu, M; Furuhata, M; Hashiguchi, A; Matsuoka, D; Naganuma, K; Noda, S; Tsukahara, T | 1 |
| He, Y; Huang, Q; Jiang, J; Li, M; Liu, X; Ma, D; Wang, S; Xu, G; Yao, Y; Zhou, J; Zou, R | 1 |
| Li, B; Oite, T; Qi, SH; Song, SM; Wang, CC; Xing, L; Yang, BF | 1 |
| Han, Z; Liang, X; Wang, H; Xing, Y; Zhou, J | 1 |
| Chihara, Y; Fujimori, T; Iidaka, K; Inada, H; Ishimitsu, T; Matsuoka, H; Ogihara, T; Ono, H; Ono, Y; Rakugi, H; Ueda, Y | 1 |
5 other study(ies) available for valsartan and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Polycythemia, capillary rarefaction, and focal glomerulosclerosis in two adolescents born extremely low birth weight and premature.
Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Antigens, CD34; Apgar Score; Biopsy; Child; Endothelial Cells; Erythropoietin; Female; Fibrosis; Glomerulosclerosis, Focal Segmental; Hemoglobins; Humans; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Kidney Glomerulus; Kidney Tubules; Male; Microvascular Rarefaction; Nephrons; Platelet Endothelial Cell Adhesion Molecule-1; Polycythemia; Pregnancy; Premature Birth; Proteinuria; Valsartan | 2017 |
Telmisartan but not valsartan inhibits TGF-beta-mediated accumulation of extracellular matrix via activation of PPARgamma.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cells, Cultured; Extracellular Matrix; Glomerulosclerosis, Focal Segmental; Mesangial Cells; PPAR gamma; Rats; Telmisartan; Tetrazoles; Transforming Growth Factor beta; Valine; Valsartan | 2008 |
Angiotensin receptor blockade attenuates glomerulosclerosis progression by promoting VEGF expression and bone marrow-derived cells recruitment.
Topics: Angiotensin Receptor Antagonists; Animals; Blotting, Western; Bone Marrow; Bone Marrow Transplantation; Disease Progression; Female; Fluorescent Antibody Technique; Glomerulosclerosis, Focal Segmental; Green Fluorescent Proteins; Immunoenzyme Techniques; Isoantibodies; Kidney Glomerulus; Male; Nephrectomy; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Receptors, Angiotensin; Tetrazoles; Thy-1 Antigens; Valine; Valsartan; Vascular Endothelial Growth Factor A | 2012 |
[Effects of the combined use of benazepril and valsartan on apoptosis in the kidney of rats with adriamycin-induced nephritic glomerulosclerosis].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Benzazepines; Doxorubicin; Drug Therapy, Combination; Fas Ligand Protein; fas Receptor; Glomerulosclerosis, Focal Segmental; Kidney; Male; Membrane Glycoproteins; Random Allocation; Rats; Rats, Sprague-Dawley; Tetrazoles; Tumor Necrosis Factors; Valine; Valsartan | 2004 |
[Angiotensin type 1 receptor blocker reduced proteinuria in patients of focal glomerular sclerosis].
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Diet, Protein-Restricted; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Losartan; Male; Methylprednisolone; Middle Aged; Prednisolone; Proteinuria; Remission Induction; Ribonucleosides; Tetrazoles; Valine; Valsartan | 2004 |